Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nancy J. Hutson currently holds 45,000 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy J. Hutson has been a net seller of PHAS stock. They have purchased $546.2K and sold $4.3M worth of shares.
Nancy J. Hutson's most recent insider trade was on Jun 20, 2024, when they sold 45,000 shares at $0.00 per share.
Nancy J. Hutson serves as Executive at PhaseBio Pharmaceuticals Inc (PHAS). They have executed 103 insider transactions totaling $4.9M over their tenure at the company.
Nancy J. Hutson holds the position of Executive at PhaseBio Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Nancy J. Hutson has shown a selling trading pattern, with $546.2K in total purchases and $4.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nancy J. Hutson was on Oct 15, 2021, when they sold $1.6M worth of BCRX shares. This transaction involved 105,000 shares at $15.40 per share.
Nancy J. Hutson currently owns 45,000 shares of PhaseBio Pharmaceuticals Inc (PHAS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nancy J. Hutson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nancy J. Hutson has 103 Form 4 filings on record as an insider at PhaseBio Pharmaceuticals Inc.
Set alerts for Nancy J. Hutson and 40,000+ other insiders.